Literature DB >> 12583240

[Effect of tanshinone IIA on CCl4-induced liver fibrosis in rats].

Yonggang Liu1, Houchang Chen, Yiping Jiang.   

Abstract

OBJECTIVE: To study the effect of tanshinone IIA on liver fibrosis in rats induced by CCl4.
METHODS: Model of liver fibrosis in rats were induced by subcutaneous injection of CCl4 and malotilate was as positive control. The histological changes were observed with light microscope. The levels of ALT, AST, NO, HA, LN in serum and Hyp, MDA in liver tissue were determined to reveal the event liver damage. RESULT: Tanshinone IIA could significantly reduce the elevate levels of ALT, AST, NO, HA, LN in serum and Hyp, MDA in liver tissue. Pathological examination suggested tanshinone IIA has therapecuical effect on experimental liver fibrosis.
CONCLUSION: Tanshinone IIA may have therapeutical effect on CCL4-induced liver fibrosis in rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12583240

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  3 in total

1.  Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.

Authors:  Asmaa A Ashour; Amal H El-Kamel; Doaa A Abdelmonsif; Hoda M Khalifa; Alyaa A Ramadan
Journal:  Int J Nanomedicine       Date:  2021-12-08

2.  Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats.

Authors:  Huanyu He; Haiying Tang; Lili Gao; Yun Wu; Zhiqiang Feng; Hongli Lin; Taihua Wu
Journal:  Mol Med Rep       Date:  2015-02-11       Impact factor: 2.952

Review 3.  Therapeutic Effect of Tanshinone IIA on Liver Fibrosis and the Possible Mechanism: A Preclinical Meta-Analysis.

Authors:  Qingji Ying; Yangyang Teng; Jing Zhang; Zhenzhai Cai; Zhanxiong Xue
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-13       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.